Budget 2025-26: Increased investment in HIV prevention and workforce
ASHM welcomes the Federal Government’s continued investment in the HIV workforce, with the announcement of $2.7 million in 2025–26 for HIV programs, including the extension of ASHM’s HIV prevention workforce education pilot. ASHM’s National PrEP Workforce Development Pilot Project aims to build Australia’s workforce capacity and break down access barriers to increase the uptake of HIV PrEP […]
New call for change in legislation for hepatitis C treatment in hospitals
A new evidence summary by Burnet Institute has revealed some people with hepatitis C in hospitals are not accessing treatment due to the cost of medication, sparking calls for the federal government to review legislation to improve access. Published jointly by Burnet Institute, Hepatitis Australia and ASHM, the summary suggests that preventing people in hospital […]
Vale Dr Nicholas Medland
ASHM, the Kirby Institute and the broader HIV and sexual health sector are mourning the loss of Dr Nicholas Medland, who passed away suddenly in the United Kingdom on Friday 21 February. Dr Nick Medland was a clinical epidemiologist at the Kirby Institute at UNSW Sydney, researching the community impact of interventions to prevent infectious […]
Highlights from HIV&AIDS 2024 and the 25th IUSTI World Congress
In September 2024, ASHM delivered two landmark conferences at ICC Sydney on Gadigal Country: the Australasian HIV&AIDS Conference 2024 and 25th IUSTI World Congress (incorporating the Australasian Sexual and Reproductive Health Conference). Together, these conferences united over 1,200 delegates from 35 countries over 5 days to discuss the latest advancements in HIV and sexual and […]
First of its kind Chemsex Toolkit for health workforce in Asia-Pacific launched
A ground-breaking Chemsex Toolkit for clinical service providers working in the Asia-Pacific region was launched at the 6th Asia Pacific Chemsex Symposium (APCS) in Bangkok, Thailand. Developed by ASHM on behalf of UNAIDS and United Nations Office on Drugs and Crime (UNODC), the Chemsex Toolkit for clinical service providers in the Asia-Pacific region is the […]
Implementing long-acting injectable HIV PrEP: Recommendations to support the Australian health sector
On the 6th of April 2024, ASHM Health organised a national workshop, funded by ViiV Healthcare, to convene a select group of key stakeholders from each Australian state and territory. The primary objective was to facilitate discussions around how to successfully implement the use of long-acting injectable cabotegravir (CAB-LA) as HIV PrEP throughout Australia and to identify […]
Combating hepatitis C in primary care
Hepatitis C virus (HCV) kills approximately 483 people in Australia each year – despite being curable in primary care. That means every death from HCV is avoidable and the elimination of hepatitis C in Australia is a very real possibility. But to get there, there is still plenty of work to do. Hepatitis C is […]
How co-design is revolutionising hepatitis B care in the Northern Territory
When studying the genotype of chronic hepatitis B (CHB) in the Northern Territory (NT), researchers discovered that 100% of CHB in Aboriginal and Torres Strait Islander peoples in the NT is due to the unique sub-genotype C4 , which is associated with quicker progression to liver cancer and cirrhosis. “It upped the urgency for us […]
Remote prescribing breaking down barriers to hepatitis C treatment in New South Wales
Hepatitis C is curable in most people. Hepatitis C treatment in the form of direct-acting antiviral medicines (DAAs) can cure more than 95% of people living with hepatitis C. While the number of people living with hepatitis C is decreasing overall, the cumulative proportion of people living with hepatitis C initiating DAA treatment remains lower […]
HIV Unwrapped
HIV Unwrapped 2024: a re-imagination of the lab coat This project is based upon the exceptional work done in the CLOAK project by the University of Technology Sydney and University of Sydney last year as part of World Pride 2023. This project extends an invitation to consider: what would a HIV scientist/researcher wear which amplifies themselves and […]
